Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112175954 | 11217595 | 4 | F | 20140923 | 20160816 | 20150625 | 20160823 | EXP | PHHY2014BR130269 | NOVARTIS | 35.14 | YR | F | Y | 0.00000 | 20160823 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112175954 | 11217595 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 1 DF, QMO | U | 21008 | 1 | DF | /month | ||||||
| 112175954 | 11217595 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | U | 21008 | |||||||||||
| 112175954 | 11217595 | 3 | SS | DOSTINEX | CABERGOLINE | 1 | Unknown | 1 DF, QW3 (AT NIGHT, 3 TIMES PER WEEK) | U | 0 | 1 | DF | TABLET | TIW | |||||
| 112175954 | 11217595 | 4 | C | TRILEPTAL | OXCARBAZEPINE | 1 | Oral | 25 MG, (1 TABLET A DAY) | 0 | 25 | MG | TABLET | |||||||
| 112175954 | 11217595 | 5 | C | CABERGOLINE. | CABERGOLINE | 1 | Oral | 0.5 MG, (1 TABLET EVERY 10 DAYS) | U | 0 | .5 | MG | TABLET | ||||||
| 112175954 | 11217595 | 6 | C | NORTRIPTYLINE | NORTRIPTYLINE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112175954 | 11217595 | 1 | Acromegaly |
| 112175954 | 11217595 | 2 | Pituitary tumour |
| 112175954 | 11217595 | 3 | Pituitary tumour |
| 112175954 | 11217595 | 4 | Headache |
| 112175954 | 11217595 | 5 | Blood growth hormone decreased |
| 112175954 | 11217595 | 6 | Sleep disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112175954 | 11217595 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112175954 | 11217595 | Abdominal pain upper | |
| 112175954 | 11217595 | Breast mass | |
| 112175954 | 11217595 | Breast pain | |
| 112175954 | 11217595 | Depression | |
| 112175954 | 11217595 | Diarrhoea | |
| 112175954 | 11217595 | Fatigue | |
| 112175954 | 11217595 | Gingival disorder | |
| 112175954 | 11217595 | Headache | |
| 112175954 | 11217595 | Hormone level abnormal | |
| 112175954 | 11217595 | Malaise | |
| 112175954 | 11217595 | Nasal dryness | |
| 112175954 | 11217595 | Pain | |
| 112175954 | 11217595 | Scab | |
| 112175954 | 11217595 | Screaming | |
| 112175954 | 11217595 | Skin exfoliation | |
| 112175954 | 11217595 | Stomach mass | |
| 112175954 | 11217595 | Vomiting | |
| 112175954 | 11217595 | Weight decreased | |
| 112175954 | 11217595 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112175954 | 11217595 | 1 | 20140922 | 0 |